INTERCEPT PHARMACEUTICALS, INC. Human Resources Contracts & Agreements

55 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (17 contracts)
Compensation Agreements (4)
Consulting Agreements (8)
Employment Agreements (24)
Non-Competition Agreements (1)
Separation Agreements (1)

Recent Contracts

2023 Equity Incentive Plan (Filed With SEC on August 2, 2023)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on August 3, 2022)
Intercept Pharmaceuticals, Inc. Amended and Restated Equity Incentive Plan (Filed With SEC on August 3, 2022)
Employment Agreement, effective April 21, 2022, between the Registrant and Rocco Venezia (Filed With SEC on May 6, 2022)
2022 Cash Incentive Plan - Form of Performance-Based Award Agreement (Filed With SEC on January 31, 2022)
2022 Cash Incentive Plan (Filed With SEC on January 31, 2022)
Employment Agreement, effective June 2, 2021, between the Registrant and M. Michelle Berrey (Filed With SEC on July 29, 2021)
Employment Agreement, effective May 17, 2021, between the Registrant and Andrew Saik (Filed With SEC on July 29, 2021)
Employment Agreement, effective February 15, 2021, between the Registrant and Linda Richardson (Filed With SEC on May 6, 2021)
Employment Agreement, effective February 9, 2021, between the Registrant and Lisa DeFrancesco (Filed With SEC on May 6, 2021)
Employment Agreement, effective January 4, 2021, between the Registrant and Bryan Ball (Filed With SEC on May 6, 2021)
Employment Agreement, effective as of December 18, 2020, between the Registrant and Jared Freedberg (Filed With SEC on February 25, 2021)
Retirement and Consulting Agreement by and between Intercept Pharmaceuticals, Inc. and Mark Pruzanski, M.D., dated December 9, 2020 (Filed With SEC on December 10, 2020)
Amended and Restated Employment Agreement by and between Intercept Pharmaceuticals, Inc. and Jerome Durso, dated December 9, 2020 (Filed With SEC on December 10, 2020)
Employment Agreement, effective June 20, 2015, between the Registrant and Richard Kim (Filed With SEC on August 10, 2020)
Employment Agreement, effective November 19, 2019, between the Registrant and Jason Campagna (Filed With SEC on February 25, 2020)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on February 25, 2020)
Employment Agreement, effective February 6, 2018, between the Registrant and Gail Cawkwell (Filed With SEC on August 8, 2019)
Employment Agreement, effective January 22, 2018, between the Registrant and Ryan Sullivan (Filed With SEC on August 8, 2019)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on May 8, 2019)
Form of Performance Share Grant Notice and Agreement (Filed With SEC on May 10, 2018)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on May 10, 2018)
Separation Agreement by and between the Registrant and Rachel McMinn, effective as of December 31, 2017 (Filed With SEC on February 28, 2018)
Employment Agreement by and between Intercept Pharmaceuticals, Inc. and David Shapiro, effective as of November 27, 2017 (Filed With SEC on December 1, 2017)
Employment Agreement by and between Intercept Pharmaceuticals, Inc. and Christian Weyer, effective as of November 27, 2017 (Filed With SEC on December 1, 2017)
EMPLOYMENT AGREEMENT (Filed With SEC on August 3, 2017)
EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2017)
EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2016)
INTERCEPT PHARMACEUTICALS, INC. NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Filed With SEC on February 17, 2016)
INTERCEPT PHARMACEUTICALS, INC. Restricted Stock Award Grant Notice forEmployees and Consultants Restricted Stock Award Grant under the Company’s 2012 Equity Incentive Plan (Filed With SEC on May 9, 2014)
INTERCEPT PHARMACEUTICALS, INC. Restricted Stock Award Grant Notice forDirectors Restricted Stock Award Grant under the Company’s 2012 Equity Incentive Plan (Filed With SEC on May 9, 2014)
EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2014)
INTERCEPT PHARMACEUTICALS, INC. NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Filed With SEC on May 9, 2014)
CONSULTING AGREEMENT (Filed With SEC on May 14, 2013)
AMENDEDAND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2013)
INTERCEPTPHARMACEUTICALS, INC. 2013 NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Filed With SEC on May 13, 2013)
AMENDMENT NO. 1 TO CONSULTING AND IP AGREEMENT (Filed With SEC on April 30, 2013)
AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 15, 2013)
AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 15, 2013)
AMENDMENT NO. 2 TO CONSULTING AND INTELLECTUAL PROPERTY(“IP”) AGREEMENT (Filed With SEC on February 22, 2013)